Want to get a preview about how you can gain valuable insights from Technavio’s market research report? Check out the latest facts about the anthrax therapeutics industry
The global anthrax therapeutics market is expected to grow at a CAGR of more than 8% during the forecast period
Anthrax treatment industry growth is expected to accelerate over the next five years, driven by development of novel therapies for treatment of anthrax. Growing threat of exposure to among the civilian population and military forces has led to the development of new therapies for anthrax treatment, which will make a positive impact on the growth of the global anthrax market. Institutes such as University of California are conducting research to treat late-stage anthrax infections, which have shown favorable results. Technavio’s anthrax treatment industry analysis reveals promising markets around the world.
Get a free sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The Americas dominated the anthrax therapeutics market by region
The global anthrax treatment market was dominated by the Americas with almost 89% of the global market share, followed by EMEA and APAC. In addition, the Americas will drive 81% of the growth for the global anthrax treatment industry, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period. The global anthrax treatment market will witness EMEA region registering the fastest rate of growth during the forecast period, while APAC will generate a higher CAGR than the Americas.
Bayer, Elusys Therapeutics, and Emergent BioSolutions are some of leading anthrax vaccine manufacturers
The global anthrax treatment market is forecasted to remain reasonably fragmented with the emergence of many international and regional anthrax vaccine companies who make drugs for the treatment of anthrax. Researchers are using a new approach called functional genomics to identify and study Bacillus anthracis proteins involved in conferring virulence to the bacterium, as the anthrax proteins’ identification would make possible the development of new generation anthrax vaccine candidates. Many established anthrax drug manufacturers are vying for their share of the global anthrax treatment market, and the new players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several anthrax vaccine companies, including:
- Bayer
- Elusys Therapeutics
- Emergent BioSolutions
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Vaccine - Market size and forecast 2018-2023
- Drug therapy - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Increase in research funding
- Increase in development of new therapies
- Development of vaccines against bioterrorism-associated anthrax
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bayer
- Elusys Therapeutics
- Emergent BioSolutions
PART 16: APPENDIX
- Research methodology
- List of abbreviations